1.5804.53% ( -0.075 )
延遲 已收盤: 11月20日 16:08:00股東
全部股東
股東類型
- 公眾及其他45.66%
- 私人企業18.59%
- 創投/私募16.21%
- 機構投資者8.94%
- 其他10.59%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
BAHEAL Pharmaceutical Holdings Limited | 18.59% | 1.11 億 | 1.52% | +906.30 萬 | 27/10/2026 |
Wuxi Biologics Healthcare Venture | 16.21% | 9,685.97 萬 | 0.00% | +0 | |
Qun XueFounder, Chairman of the Board, CEO & Member of Strategic Advisory Board | 7.04% | 4,203.58 萬 | 0.03% | +15.43 萬 | 13/11/2026 |
WuXi AppTec Co., Ltd. | 3.44% | 2,055.49 萬 | 0.00% | +0 | 31/12/2025 |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 3.39% | 2,023.83 萬 | 0.00% | +0 | 19/05/2025 |
WuXi PharmaTech Healthcare Fund I General Partner L.P. | 3.31% | 1,979.21 萬 | 0.00% | +0 | 31/12/2025 |
Athos Capital Limited | 1.91% | 1,141.26 萬 | 0.00% | +0 | 31/12/2025 |
New Holland Capital, LLC | 0.20% | 120.40 萬 | 0.00% | +0 | 31/12/2025 |
BlackRock, Inc. | 0.13% | 79.00 萬 | <0.01% | +5.60 萬 | 30/10/2026 |
James Arthur GeraghtyIndependent Non-Executive Director | 0.12% | 70.00 萬 | 0.00% | +0 | |
State Street Investment Management | 0.00% | 0.00 | 0.05% | -28.60 萬 | 21/11/2026 |
